Recro Strengthens Leadership Team With Key Executive and Board Appointments
February 11, 2021 07:00 ET
|
Recro Pharma, Inc.
Company Names CDMO Industry Thought Leader, Jim Miller, to Board of Directors and Selects Ryan D. Lake as Dedicated Chief Financial OfficerRecent Appointments, including CEO David Enloe, Provide...
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
January 11, 2021 08:00 ET
|
LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Germany-based formulation development specialist Leukocare opens US presence to support local...
Starton Therapeutics Selects Formulation for Continuous Subcutaneous Lenalidomide Delivery System for CLL Treatment
January 11, 2021 07:40 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in...
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
May 21, 2020 06:30 ET
|
Shah Capital
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...
Nexeo Solutions Launches New Sampling Site Focused on Personal Care Innovation
December 13, 2018 06:00 ET
|
Nexeo Solutions, Inc.
THE WOODLANDS, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Nexeo Solutions, Inc. (NASDAQ:NXEO), a leader in chemicals and plastics distribution, announced the launch of its formulations services...
Acne Medication Market revenue worth over $7 billion by 2024: Global Market Insights, Inc.
November 29, 2018 07:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Brazil dominated the Latin America acne medication market and was valued at over USD 110.9 million in the year 2017. Growing prevalence...
Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products
October 03, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) has entered into a research agreement with VivaCell...
Emerald Health Therapeutics Completes Acquisition of Licensed Dealer Northern Vine Canada
August 15, 2018 14:52 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (Emerald) has completed the purchase of the remaining shares of Northern Vine...
Avantor Opens New Life Sciences Research Center
July 18, 2017 12:03 ET
|
Avantor
CENTER VALLEY, PA--(Marketwired - July 18, 2017) - Avantor®, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, has opened a new...
Minerva Announces Completion of Bridging Study to Select Improved Formulation of MIN-101 for Use in Phase 3 Trial for the Treatment of Negative Symptoms in Patients With Schizophrenia
June 22, 2017 08:30 ET
|
Minerva Neurosciences, Inc.
New formulation observed to improve safety margin while offering bioequivalent exposure to prior formulation Company to proceed with initiation of Phase 3 trial on schedule in second half of 2017 ...